Am J Respir Crit Care Med . Case Fatality Rates for COVID-19 Patients Requiring Invasive Mechanical Ventilation: A Meta-analysis

[tetano]

Am J Respir Crit Care Med


. 2020 Oct 29.
doi: 10.1164/rccm.202006-2405OC. Online ahead of print.
Case Fatality Rates for COVID-19 Patients Requiring Invasive Mechanical Ventilation: A Meta-analysis


Zheng Jie Lim ¹ , Ashwin Subramaniam ^{2 3} , Mallikarjuna Ponnapa Reddy ² , Gabriel Blecher ^{4 5} , Umesh Kadam ^{6 7 8} , Afsana Afroz ^{9 10} , Baki Billah ⁹ , Sushma Ashwin ¹¹ , Mark Kubicki ¹² , Federico Bilotta ¹³ , J Randall Curtis ¹⁴ , Francesca Rubulotta ¹⁵



Affiliations

• PMID: 33119402
• DOI: 10.1164/rccm.202006-2405OC

Abstract

Rationale: Initial reports of case fatality rates (CFR) among adults with coronavirus diease-19 (COVID-19) receiving invasive medical ventilation (IMV) are highly variable.
Objective: To examine the CFR of patients with COVID-19 receiving IMV.
Methods: Two authors independently searched PubMed, Embase, medRxiv, bioRxiv, the COVID-19 living systematic review, and national registry databases. The primary outcome was the "reported CFR" for patients with confirmed COVID-19 requiring IMV. "Definitive hospital CFR" for patients with outcomes at hospital discharge was also investigated. Finally, CFR was analyzed by patient age, geographic region, and study quality based on the Newcastle-Ottawa Scale.
Results: Sixty-nine studies were included, describing 57,420 adult patients with COVID-19 who received IMV. Overall reported CFR was estimated as 45% (95% CI 39-52%). Fifty-four out of 69 studies stated whether hospital outcomes were available but provided a definitive hospital outcome on only 13,120 (22.8%) of the total IMV patient population. Among studies where age-stratified CFR was available, pooled CFR estimates ranged from 47.9% (95% CI 46.4-49.4%) in younger patients (age ≤40) to 84.4% (95% CI 83.3-85.4) in older patients (age >80). CFR was also higher in early COVID-19 epicenters. Overall heterogeneity is high (I2>90%) with non-significant Egger's regression test suggesting no publication bias.
Conclusion: Almost half of COVID-19 patients receiving IMV died, based on the reported CFR, but variable CFR reporting methods resulted in a wide range of CFR between studies. Reported CFR was higher in older patients and in early pandemic epicenters, which may be influenced by limited ICU resources. Reporting of definitive outcomes on all patients would facilitate comparisons between studies. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).